drugset / Trial / NCT04769583

14-day Quadruple Therapy Versus Triple Therapy in HP Eradication

NCT04769583

Phase 4 Completed 121 enrolled mohamed bouchoucha
RandomizedParallel-groupTriple-blindTreatment

Summary

In this prospective randomized-controlled study, treatment-naive H. pylori-infected patients are randomized to receive either standard triple therapy or sequential therapy. The aim is to compare the efficacy of concomitant quadruple therapy with standard triple therapy as a first line treatment for H. pylori infection in Tunisian patients.

Timeline

Start
2019-02-10
Primary completion
2020-02-17
Completion
2020-03-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 500 mg
Comparator Amoxicillin Other / unclassified 1 g
Comparator Clarithromycin Small molecule 500 mg
Comparator Esomeprazole Small molecule 40 mg

Indications